Clinic
Wabash Valley Health Center, INC.
Wabash Valley Health Center, INC. was paid $5.90M by Medicaid between Jan 2018 and Dec 2024, across 66 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoWABASH VALLEY HEALTH CENTER, INC.
TERRE HAUTE, IN 47807
TERRE HAUTE, IN 47807
33aNPI1376974527assigned 12/12/2013
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$5.90M
24GClaims163,333
24DCodes billed66
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Indiana
Rank by total paid#15 of 156
Median peer was paid$568K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,647 | $152K | |
| 2019 | 12,600 | $707K | |
| 2020 | 14,472 | $731K | |
| 2021 | 30,434 | $1.20M | |
| 2022 | 36,953 | $1.19M | |
| 2023 | 33,914 | $1.14M | |
| 2024incomplete | 23,313 | $783K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 31,908 | 26,491 | $1.53M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 15,442 | 13,107 | $1.08M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 13% | 39,078 | 31,048 | $775K |
| D7140 | Extraction, erupted tooth or exposed root | 7.0% | 6,326 | 2,067 | $411K |
| D9999 | Unspecified adjunctive procedure, by report | 4.0% | 10,538 | 8,618 | $237K |
| D0999 | Unspecified diagnostic procedure, by report | 3.7% | 1,654 | 1,476 | $216K |
| D1110 | Prophylaxis - adult | 3.5% | 4,676 | 4,170 | $207K |
| D0330 | Panoramic radiographic image | 3.2% | 3,336 | 3,010 | $191K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.8% | 1,290 | 921 | $107K |
| D0150 | Comprehensive oral evaluation - new or established patient | 1.8% | 3,159 | 2,863 | $104K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 1.6% | 4,648 | 4,168 | $95K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.5% | 1,637 | 1,233 | $87K |
54 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.3% | 1,695 | $77K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 1.2% | 1,399 | $72K |
| D0140 | Limited oral evaluation - problem focused | 1.2% | 2,132 | $71K |
| 90832 | Psychotherapy session, about 30 minutes | 1.2% | 2,095 | $70K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 1.1% | 955 | $64K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 897 | $60K |
| D0274 | Bitewings - four radiographic images | <1% | 1,766 | $57K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,157 | $54K |
| G0467 | Community health center visit, returning patient | <1% | 4,760 | $53K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 379 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,172 | $30K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,865 | $26K |
| D2330 | <1% | 348 | $25K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 229 | $19K |
| 90686 | <1% | 1,498 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,297 | $17K |
| D2331 | <1% | 156 | $16K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 661 | $15K |
| 90674 | <1% | 714 | $13K | |
| D1206 | Topical application of fluoride varnish | <1% | 580 | $9K |
| D1120 | Dental cleaning, child | <1% | 326 | $7K |
| D4910 | <1% | 132 | $6K | |
| 36416 | <1% | 2,862 | $6K | |
| 90732 | <1% | 82 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 393 | $5K |
| 90715 | <1% | 138 | $4K | |
| 0134A | <1% | 145 | $4K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 675 | $3K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 51 | $3K |
| 90677 | <1% | 13 | $3K | |
| 90480 | <1% | 222 | $3K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 191 | $2K |
| 0064A | <1% | 100 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,237 | $2K |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 15 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 58 | $1K |
| 81003 | <1% | 582 | $1K | |
| 81025 | <1% | 181 | $757.24 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 25 | $690.25 |
| 82962 | <1% | 241 | $543.21 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 36 | $487.79 |
| 80305 | <1% | 87 | $397.01 | |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 70 | $361.37 |
| 82948 | <1% | 111 | $227.11 | |
| 93000 | <1% | 14 | $154.69 | |
| 91322 | <1% | 199 | $134.50 | |
| 81002 | <1% | 315 | $125.31 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $19.74 |
| 91313 | 0% | 141 | $0.00 | |
| 90756 | 0% | 18 | $0.00 | |
| 90651 | 0% | 14 | $0.00 | |
| 91301 | 0% | 19 | $0.00 | |
| 91306 | 0% | 103 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 73 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCIANCONE, PETER (PRESIDENT OF THE BOARD OF DIRECTORS)